Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.
about
PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation.Advancing Immune and Cell-Based Therapies Through Imaging.Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancerChemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
P2860
Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of tumor response t ...... apy in malignant solid tumors.
@ast
Evaluation of tumor response t ...... apy in malignant solid tumors.
@en
Evaluation of tumor response t ...... apy in malignant solid tumors.
@nl
type
label
Evaluation of tumor response t ...... apy in malignant solid tumors.
@ast
Evaluation of tumor response t ...... apy in malignant solid tumors.
@en
Evaluation of tumor response t ...... apy in malignant solid tumors.
@nl
prefLabel
Evaluation of tumor response t ...... apy in malignant solid tumors.
@ast
Evaluation of tumor response t ...... apy in malignant solid tumors.
@en
Evaluation of tumor response t ...... apy in malignant solid tumors.
@nl
P2093
P2860
P921
P1476
Evaluation of tumor response t ...... apy in malignant solid tumors.
@en
P2093
Binfeng Lu
Chang-Ping Wu
Jing-Ting Jiang
Xiao Zheng
Xiao-Dong Li
Zhong-Hua Ning
P2860
P2888
P356
10.1186/S12967-014-0215-0
P5008
P577
2014-08-12T00:00:00Z
P5875
P6179
1029823557